Trial Profile
A Prospective Open-Label Treatment Trial of Asenapine Monotherapy in subjects at Clinical High Risk for Psychosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Aug 2014
Price :
$35
*
At a glance
- Drugs Asenapine (Primary)
- Indications Psychotic disorders
- Focus Therapeutic Use
- 06 Aug 2014 New trial record